Business
Pfizer says antiviral pill cuts risk of severe COVID-19 by nearly 90 per cent – Sydney Morning Herald
The results for Pfizer’s antiviral pill appear to surpass those seen with Merck & Co Inc’s pill molnupiravir.
Antivirals need to be given as early as possible, before an infection takes hold, in order to be most effective. Merck tested its drug within five days of symptom onset.
We saw that we did have high efficacy, even if it was five days after a patient has…
Continue Reading
-
Business21 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General15 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News17 hours agoTips to improve engagement – Proctor
-
Noosa News20 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland